We welcome clinical and molecular data from patients with pathogenic PTENvariants in order to improve genotype-phenotype correlations, refine natural history, and better define surveillance needs. Ongoing collaborative projects may include longitudinal follow-up, standardized phenotyping, and collection of tumor and neurodevelopmental outcomes. Clinicians interested in collaboration are encouraged to contact the moderators.
PTEN